跳至主要内容
临床试验/NCT05437965
NCT05437965招募中不适用

National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年6月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Target vessel failure

研究概览

简要总结

This project aims to establish a clinical cohort and diagnostic assessment framework by conducting a national multicenter cohort registry study. Through the collection of patients' clinical characteristics, it will achieve the registration, management, follow-up, and analysis of patients with Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years;
  • Patients meeting the diagnostic criteria for Rapid rEcurrences of Coronary Unexplained in-stent Restenosis (RECUR);
  • Patients fully informed about the trial procedures who provide written informed consent.

排除标准

  • Patients presenting with any of the following:
  • Other severe comorbidities (e.g., malignant tumors, heart failure) with a life expectancy <12 months;
  • Known autoimmune/rheumatic diseases including systemic lupus erythematosus, Takayasu arteritis, Behçet's disease, polyarteritis nodosa, Wegener granulomatosis (granulomatosis with polyangiitis), eosinophilic arteritis, giant cell arteritis, rheumatoid arthritis, or IgG4-related disease;
  • Variant angina (Prinzmetal's angina);
  • Coronary artery dissection;
  • Thrombophilia;
  • Stent underexpansion.
  • Presence of psychiatric disorders;
  • Known inability to complete expected study follow-up for any reason;
  • Patients deemed ineligible for enrollment by the investigator.

结局指标

主要结局

Target vessel failure

时间窗: 10 year

Time to the incidence of target vessel failure, a composite of cardiovascular death, target vessel-related myocardial infarction, and target vessel-related revascularization.

次要结局

未报告次要终点

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Kefei Dou, MD

Director of the Department of Internal Medicine

China National Center for Cardiovascular Diseases

研究点 (1)

Loading locations...

相似试验